Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul 10:2:185-96.

Biomarker discovery in animal health and disease: the application of post-genomic technologies

Affiliations

Biomarker discovery in animal health and disease: the application of post-genomic technologies

Rowan E Moore et al. Biomark Insights. .

Abstract

The causes of many important diseases in animals are complex and multifactorial, which present unique challenges. Biomarkers indicate the presence or extent of a biological process, which is directly linked to the clinical manifestations and outcome of a particular disease. Identifying biomarkers or biomarker profiles will be an important step towards disease characterization and management of disease in animals. The emergence of post-genomic technologies has led to the development of strategies aimed at identifying specific and sensitive biomarkers from the thousands of molecules present in a tissue or biological fluid. This review will summarize the current developments in biomarker discovery and will focus on the role of transcriptomics, proteomics and metabolomics in biomarker discovery for animal health and disease.

Keywords: Biomarker; Metabolomics; Proteomics; Transcriptomics; Veterinary.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Post-genomic approaches to biomarker discovery. Post-genomic technologies have provided new avenues for biomarker discovery. Biological fluids and tissues hold a wealth of information at the transcript, protein and metabolite level which may be able to characterize disease states in animals. The identification of diagnostically relevant biomarkers requires rigorous validation before use in the clinic.

Similar articles

Cited by

References

    1. Abdul-Careem MF, Hunter BD, Nagy E, et al. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek’s disease virus genome load in feather tips. J Virol Methods. 2006;133:34–40. - PubMed
    1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198–207. - PubMed
    1. Anderson NL, Anderson NG. The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol Cell Proteomics. 2005;4:1441–4. - PubMed
    1. Aronson JK. Biomarkers and surrogate endpoints. Brit J Clin Pharmacol. 2005;59:491–4. - PMC - PubMed
    1. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-ToF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 2004;20:777–85. - PubMed

LinkOut - more resources